email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
2941 - 2955
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Prenetics Acquires British Consumer Genetic Testing Firm
$5.00
Available
Philip Partners with Digital China Health to Launch Cloud-Based Imaging Services
$5.00
Available
Qiming Closes $120 Million US Healthcare Fund, Two General China Funds with $1.2 Billion
$5.00
Available
Shuwen Biotech Reports "Multi-Million Dollar" Investment from Tasly
$5.00
Available
Suzhou Alphamab to Start China Trial of Bispecific HER2 Inhibitor
$5.00
Available
Ping An Healthcare and Technology Plans $1 Billion HK IPO for May
$5.00
Available
MabSpace Starts US Trial of PD-L1 Drug; China Trial to Begin Soon
$5.00
Available
Beijing's AK Medical Buys JRI Orthopedics of the UK for $24 Million
$5.00
Available
Beigene Initiated Global Phase II Clinical Trial for PD-1 Antibody
$5.00
Available
Biocytogen Closes $65 Million Round for Animal Model CRO Services
$5.00
Available
DXY Completes $100 Million Series D Round for China Doctor Academic Portal
$5.00
Available
Bliss Biopharma of Hangzhou Licenses Cancer ADC from Morphotek
$5.00
Available
Panacea Ventures Files to Raise $150 Million for China Healthcare
$5.00
Available
New World Development Invests in New Century Healthcare; Plans More China Clinics/Hospitals
$5.00
Available
Frontage Labs, a US-China CRO, Acquires Concord Biosciences
$5.00
Available